The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
The Prevalence of Huntington's Disease
Open accessAbstract
Background: Reviews of the epidemiology of Huntington's disease (HD) suggest that its worldwide prevalence varies widely. This review was undertaken to confirm these observations, to assess the extent to which differences in case-ascertainment and/or diagnosis might be responsible, and to investigate whether the prevalence pattern has changed over the past 50 years. Methods: Eighty two relevant studies were identified from Medline and Embase, previous reviews, scrutiny of references from included and excluded studies and enquiry among those interested in the field. Results: The lowest rates were among the Asians and the highest among the Caucasians. The differences are not fully explained by varying approaches to case-ascertainment or diagnosis. There was evidence of an increasing prevalence of between 15 and 20% per decade in studies from Australia, North America and Western Europe. Conclusions: The prevalence of HD varies more than tenfold between different geographical regions. This variation can in part be attributed to differences in case-ascertainment and/or diagnostic criteria, but there is consistent evidence of a lower incidence in Asian populations. There is also evidence that in Australia, North America and in Western Europe (including the United Kingdom), prevalence has increased over the past 50 plus years.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & for the PRISMA Group (2009) · BMJ · doi:10.1136/bmj.b2535 · Cited by 83,823
Measuring inconsistency in meta-analyses
Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003) · BMJ · doi:10.1136/bmj.327.7414.557 · Cited by 63,139
Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & the PRISMA Group* (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-151-4-200908180-00135 · Cited by 37,554
Shah, M. A., Datson, N. A., Srinidhi, L., Stanton, V. P., MacDonald, M. E., Allard, M. W., Youngman, S., Am, F., Mott, R., Draths, K., et al. (1993) · Cell · Cited by 3,055
Self-citationThe incidence and prevalence of Huntington's disease: A systematic review and meta‐analysis
Pringsheim, T., Wiltshire, K., Day, L., Dykeman, J., Steeves, T., & Jette, N. (2012) · Movement Disorders · doi:10.1002/mds.25075 · Cited by 587
The epidemiology of Huntington's disease
Harper, P. (1992) · Human Genetics · doi:10.1007/bf00194305 · Cited by 328
Novak, M. J. U., & Tabrizi, S. J. (2010) · BMJ · doi:10.1136/bmj.c3109 · Cited by 244
Self-citationEvans, S. J., Douglas, I., Rawlins, M. D., Wexler, N. S., Tabrizi, S. J., & Smeeth, L. (2013) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2012-304636 · Cited by 207
Self-citationHuntington disease: genetics and epidemiology.
Conneally, P. M. (1984) · PubMed · Cited by 202
Multisource ascertainment of Huntington disease in Canada: Prevalence and population at risk
Fisher, E. R., & Hayden, M. R. (2014) · Movement Disorders · doi:10.1002/mds.25717 · Cited by 173
Warby, S. C., Visscher, H., Collins, J. A., Doty, C. N., Carter, C., Butland, S. L., Hayden, A. R., Kanazawa, I., Ross, C. J., & Hayden, M. R. (2011) · European Journal of Human Genetics · doi:10.1038/ejhg.2010.229 · Cited by 167
The Prevalence of Juvenile Huntington's Disease: A Review of the Literature and Meta-Analysis
Quarrell, O. W. J., O’Donovan, K., Bandmann, O., & Strong, M. (2012) · PLoS Currents · doi:10.1371/4f8606b742ef3 · Cited by 146
Epidemiology of neurodegenerative diseases in sub-Saharan Africa: a systematic review
Lekoubou, A., Echouffo-Tcheugui, J. B., & Kengne, A. P. (2014) · BMC Public Health · doi:10.1186/1471-2458-14-653 · Cited by 141
Huntington disease in Maryland: clinical aspects of racial variation.
Folstein, S. E., Chase, G. A., Wahl, W. E., McDonnell, A. M., & Folstein, M. F. (1987) · Europe PMC (PubMed Central) · Cited by 124
Almqvist, E. W., Elterman, D., Macleod, P., & Hayden, M. R. (2001) · Clinical Genetics · doi:10.1034/j.1399-0004.2001.600305.x · Cited by 94
Ramos‐Arroyo, M. A., Moreno, S., & Valiente, A. (2005) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2004.036806 · Cited by 91
Wexler, N. S., Collett, L., Wexler, A. R., Rawlins, M. D., Tabrizi, S. J., Douglas, I., Smeeth, L. L., & Evans, S. J. W. (2016) · BMJ Open · doi:10.1136/bmjopen-2015-009070 · Cited by 75
Self-citationParadisi, I., Hernández, A., & Arias, S. (2007) · Journal of Human Genetics · doi:10.1007/s10038-007-0227-1 · Cited by 59
A Systematic Review of the Incidence and Prevalence of Long-Term Neurological Conditions in the UK
Hoppitt, T., Pall, H., Calvert, M., Gill, P. S., Yao, G., Ramsay, J., James, G., Conduit, J., & Sackley, C. M. (2010) · Neuroepidemiology · doi:10.1159/000321712 · Cited by 56
Paradisi, I., Hernández, A., & Arias, S. (2008) · Journal of Human Genetics · doi:10.1007/s10038-008-0256-4 · Cited by 50
Huntington's Disease: Advocacy Driving Science
Wexler, N. S. (2011) · Annual Review of Medicine · doi:10.1146/annurev-med-050710-134457 · Cited by 44
Self-citationEpidemiology of Huntington disease: first post‐HTT gene analysis of prevalence in Italy
Squitieri, F., Griguoli, A., Capelli, G., Porcellini, A., & D'Alessio, B. (2016) · Clinical Genetics · doi:10.1111/cge.12574 · Cited by 43
Xu, M., & Wu, Z. (2015) · Chinese Medical Journal · doi:10.4103/0366-6999.159359 · Cited by 40
Late-onset Huntington's disease: Diagnostic and prognostic considerations
Koutsis, G., Karadima, G., Kladi, A., & Πάνας, Μ. (2014) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2014.03.017 · Cited by 40
Juvenile Huntington's disease: a population-based study using the General Practice Research Database
Douglas, I., Evans, S. J. W., Rawlins, M. D., Smeeth, L. L., Tabrizi, S. J., & Wexler, N. S. (2013) · BMJ Open · doi:10.1136/bmjopen-2012-002085 · Cited by 31
Self-citationClinical and Molecular Features of Late Onset Huntington Disease in a Peruvian Cohort
Cornejo‐Olivas, M., Inca‐Martinez, M., Espinoza-Huertas, K., Véliz-Otani, D., Velit-Salazar, M. R., Marca, V., Ortega, O., Cornejo-Herrera, I., Lindo-Samanamud, S., Mora-Alferez, A. P., et al. (2015) · Journal of Huntington s Disease · doi:10.3233/jhd-140119 · Cited by 29
The Frequency of Inherited Disorders Database: Prevalence of Huntington Disease
Al-Jader, L. N., Harper, P. S., Krawczak, M., & Palmer, S. (2001) · Public Health Genomics · doi:10.1159/000051175 · Cited by 20
Cited by
Inflammation in CNS neurodegenerative diseases
Stephenson, J., Nutma, E., van der Valk, P., & Amor, S. (2018) · Immunology · doi:10.1111/imm.12922 · Cited by 966
A Survey of Healthcare Internet of Things (HIoT): A Clinical Perspective
Habibzadeh, H., Dinesh, K., Rajabi Shishvan, O., Boggio-Dandry, A., Sharma, G., & Soyata, T. (2020) · IEEE Internet of Things Journal · doi:10.1109/jiot.2019.2946359 · Cited by 417
Role of Plant Derived Alkaloids and Their Mechanism in Neurodegenerative Disorders
Hussain, G., Rasul, A., Anwar, H., Aziz, N., Razzaq, A., Wei, W., Ali, M., Li, J., & Li, X. (2018) · International Journal of Biological Sciences · doi:10.7150/ijbs.23247 · Cited by 351
Elfawy, H. A., & Das, B. (2019) · Life Sciences · doi:10.1016/j.lfs.2018.12.029 · Cited by 343
Drug Repurposing for Rare Diseases
Roessler, H. I., Knoers, N. V. A. M., van Haelst, M. M., & van Haaften, G. (2021) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2021.01.003 · Cited by 269
Metadata
- Authors
- Rawlins, M. D., Wexler, N. S., Wexler, A. R., Tabrizi, S. J., Douglas, I., Evans, S. J. W., & Smeeth, L.
- Venue
- Neuroepidemiology
- Publisher
- S. Karger AG
- Published
- 2016
- Volume
- 46
- Issue
- 2
- Pages
- 144-153
- ISSN
- 0251-5350 (ISSN-L)
- 1423-0208
- OpenAlex
- W2256392690
- Cited by
- 331
- References
- 27
- FWCI
- 13.85
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.